Posted by Michael Wonder on 20 Jan 2019
Expensive lung cancer drug added to PBS
20 January 2019 - A drug that helps patients suffering lung cancer has been added to the Pharmaceutical Benefits Scheme.
Australians with lung cancer could save as much as $90,000 a year after the federal government announced the listing of a cancer-fighting pill on the Pharmaceutical Benefits Scheme.
The subsiding of Tagrisso from February 1 will bring down the cost of an individual script from $8000 - or $88,000 for an entire year of treatment - to a maximum of $40.30 per script.
